Automate Your Wheel Strategy on MDT
With Tiblio's Option Bot, you can configure your own wheel strategy including MDT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MDT
- Rev/Share 26.1538
- Book/Share 37.6324
- PB 2.4683
- Debt/Equity 0.5938
- CurrentRatio 1.8491
- ROIC 0.0608
- MktCap 118439674400.0
- FreeCF/Share 4.0435
- PFCF 22.8428
- PE 25.4205
- Debt/Assets 0.311
- DivYield 0.0304
- ROE 0.0962
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | MDT | Wolfe Research | Underperform | Peer Perform | -- | -- | June 30, 2025 |
| Initiation | MDT | Leerink Partners | -- | Outperform | -- | $110 | June 16, 2025 |
| Upgrade | MDT | Citigroup | Neutral | Buy | $92 | $107 | March 4, 2025 |
| Upgrade | MDT | RBC Capital Mkts | Sector Perform | Outperform | $98 | $105 | Oct. 10, 2024 |
| Reiterated | MDT | Oppenheimer | -- | Perform | $92 | $94 | Aug. 21, 2024 |
News
Prediction: Buying Medtronic Today Will Set You Up for Life
Published: March 28, 2025 by: The Motley Fool
Sentiment: Positive
Healthcare can be a complex sector, and it is one that I long ago decided to outsource to the industry professionals who run closed-end fund Blackrock Health Sciences Trust. But I couldn't resist dipping my toe into the sector when I saw the historically high yield on offer from Medtronic (MDT 0.88%), one of the largest and most diversified medical device makers.
Read More
2 Recession-Proof Dividend Stocks to Buy and Hold
Published: March 27, 2025 by: The Motley Fool
Sentiment: Neutral
Fears of a looming recession seem to be rising, partly fueled by President Donald Trump's macroeconomic policies. While it's impossible to predict whether an economic downturn is indeed coming, it's not a bad idea for investors to purchase shares of companies that are likely to perform relatively well in case it does happen.
Read More
Does the S&P 500 Rally Make MDT Stock a Buy Amid Easing Trade Tension?
Published: March 25, 2025 by: Zacks Investment Research
Sentiment: Neutral
Medtronic's Hypertension business is on the brink of a major expansion, driven by its Simplicity blood pressure procedure.
Read More
Watch These 5 AI-Powered Healthcare Bigwigs for Portfolio Gains
Published: March 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Five AI-powered stocks have strong revenues and earnings growth potentials for 2025. These are: MDT, LLY, BSX, NVS, ABT.
Read More
Medtronic: Strength In Cardiac Ablation Solutions, Upgrade To Buy
Published: March 19, 2025 by: Seeking Alpha
Sentiment: Positive
Upgraded Medtronic to a ‘Buy' rating with a fair value of $105 per share, driven by strong growth in Cardiac Ablation Solutions and TAVR markets. Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth, highlighting significant momentum in its Cardiac Ablation Solutions business. The company's structural heart business, especially the Evolut FX+ TAVR system, is showing strong adoption and competitive advantages over Edwards Lifesciences's SAPIEN TAVR product.
Read More
FDA classifies recall of Medtronic embolization devices as 'most serious'
Published: March 18, 2025 by: Reuters
Sentiment: Negative
The U.S. Food and Drug Administration on Tuesday classified the recall of Medtronic's embolization device as "most serious", following reports of the deaths of four patients.
Read More
Dividend Kings Of The Future
Published: March 18, 2025 by: Seeking Alpha
Sentiment: Positive
A list of 9 companies that may reach Dividend King status in the near future. These companies span various sectors and offer investors a wide range of dividend growth rates and yields. A few of these companies have abnormally high payout ratios, which may hinder their ability to achieve Dividend King status.
Read More
Why Medtronic (MDT) is a Top Momentum Stock for the Long-Term
Published: March 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
NVIDIA's AI Speeds Up MedTech's Digital Boom: 3 Stocks in Focus
Published: March 12, 2025 by: Zacks Investment Research
Sentiment: Positive
RMD, GEHC and MDT are expected to thrive as NVIDIA and other AI leaders' MedTech ventures accelerate digital adoption within the space.
Read More
The Big 3: KO, MDT, LHX
Published: March 11, 2025 by: Schwab Network
Sentiment: Positive
Stability is Kenny Polcari's theme when it comes to today's Big 3. He explains why Cola-Cola (KO), Medtronic (MDT) and L3Harris (LHX) are undervalued names with quality.
Read More
Positive Trial Data on Evolut TAVR Likely to Support MDT Stock
Published: March 10, 2025 by: Zacks Investment Research
Sentiment: Positive
At the CRT conference 2025, Medtronic presented two-year favorable SMART trial data, which demonstrated the superior performance of the Evolut TAVR valve in patients with AS.
Read More
Medtronic explores options to optimize manufacturing operations amid Trump's tariff threats
Published: February 25, 2025 by: Reuters
Sentiment: Neutral
Medical device maker Medtronic is looking at options to modify its global manufacturing footprint as part of efforts to mitigate any impact of U.S. President Donald Trump's tariff plans, a company executive told Reuters on Tuesday.
Read More
Distributor Purchasing Shifts Mar MDT's Q3 Show: How to Play the Stock
Published: February 24, 2025 by: Zacks Investment Research
Sentiment: Negative
Medtronic's Medical Surgical segment faces challenges in the third quarter due to shifts in U.S. distributor buying patterns.
Read More
Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's
Published: February 24, 2025 by: PRNewsWire
Sentiment: Neutral
New closed-loop system self-adjusts DBS therapy to individual brain activity in real time; the largest commercial launch of brain-computer interface technology ever GALWAY, Ireland , Feb. 24, 2025 /PRNewswire/ -- For the one million people diagnosed with Parkinson's disease in the United States 1, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug Administration (FDA) approval of BrainSense™ Adaptive deep brain stimulation (aDBS) and BrainSense™ Electrode Identifier (EI). There is no cure for debilitating neurological conditions like Parkinson's, however, deep brain stimulation (DBS) has been transforming the lives of people with Parkinson's and other …
Read More
Medtronic's Expansion Gains Momentum—Time for a Market Shift?
Published: February 21, 2025 by: MarketBeat
Sentiment: Positive
Medtronic's NYSE: MDT growth efforts and investments in medical technology innovation are starting to pay off. The company's pulsed field ablation (PFA) technology is a key growth driver, strengthening both its cardiac segment and overall business expansion.
Read More
The Smartest Dividend Stocks to Buy With $1,000 Right Now
Published: February 20, 2025 by: The Motley Fool
Sentiment: Positive
You have $1,000 (or $200 or $50,000) burning a hole in your pocket and you're itching to invest in some stocks. Might I suggest some dividend payers?
Read More
Why Medtronic Stock Is Sinking Today
Published: February 18, 2025 by: The Motley Fool
Sentiment: Negative
Shares of Medtronic (MDT -6.63%) were sinking 7.3% as of 11:21 a.m. ET on Tuesday.
Read More
Empire State Manufacturing Increase More Than Expected
Published: February 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Pre-market futures are starting a new holiday-shortened trading week higher, with all four major indexes currently riding in the green. The Dow is +81 points at this hour, the S&P 500 is +23, the Nasdaq +96 points and the small-cap Russell 2000 +9.
Read More
Medtronic plc (MDT) Q3 2025 Earnings Call Transcript
Published: February 18, 2025 by: Seeking Alpha
Sentiment: Neutral
Medtronic plc (NYSE:MDT ) Q3 2025 Earnings Conference Call February 18, 2025 8:00 AM ET Company Participants Ryan Weispfenning - Vice President and Head of Investor Relations Geoff Martha - Chairman and Chief Executive Officer Gary Corona - Interim Chief Financial Officer Brad Welnick - Vice President, Investor Relations Sean Salmon - Executive Vice President and President, Cardiovascular Portfolio Mike Marinaro - Executive Vice President and President, Medical Surgical Portfolio and Americas Conference Call Participants Patrick Wood - Morgan Stanley Larry Biegelsen - Wells Fargo Robbie Marcus - JP Morgan Vijay Kumar - Evercore ISI Travis Steed - Bank of …
Read More
Medtronic (MDT) Tops Q3 Earnings Estimates
Published: February 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Medtronic (MDT) came out with quarterly earnings of $1.39 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.30 per share a year ago.
Read More
Medtronic (MDT) Increases Yet Falls Behind Market: What Investors Need to Know
Published: February 13, 2025 by: Zacks Investment Research
Sentiment: Neutral
In the closing of the recent trading day, Medtronic (MDT) stood at $92.20, denoting a +0.93% change from the preceding trading day.
Read More
3 High-Yield Dividend Stocks I Can't Wait to Buy to Boost My Passive Income
Published: February 13, 2025 by: The Motley Fool
Sentiment: Positive
I'm about to get a big cash infusion in my portfolio. Last year, private equity giant Blackstone agreed to buy one of my holdings, Retail Opportunity Investments Corp. , in an all-cash deal.
Read More
Retirement Strategy: 2 Dividend Aristocrats At Bargain Prices
Published: February 12, 2025 by: Seeking Alpha
Sentiment: Positive
Buying battle-tested dividend aristocrats can be a winning strategy for those seeking durable retirement income. What's even better is if they also carry strong balance sheets and are attractively valued. In this article, I highlight 2 such picks, which, on a combined basis, offer immediate diversification and potential for market-beating total returns.
Read More
MDT Stock Trades Cheaper Than Peers Ahead of Q3 Earnings: Time to Buy?
Published: February 11, 2025 by: Zacks Investment Research
Sentiment: Negative
Medtronic expects its fiscal 2025 third-quarter revenues to reflect an unfavorable impact of 1% from currency translation.
Read More
About Medtronic plc (MDT)
- IPO Date 1973-05-02
- Website https://www.medtronic.com
- Industry Medical - Devices
- CEO Geoffrey Straub Martha
- Employees 95000